InvestorsHub Logo
Followers 129
Posts 23648
Boards Moderated 1
Alias Born 09/14/2016

Re: None

Monday, 05/09/2022 1:28:22 PM

Monday, May 09, 2022 1:28:22 PM

Post# of 17492
Incannex Healthcare Limited (NASDAQ: $IXHL ) (ASX: IHL), ('Incannex' or the 'Company') a clinical stage pharmaceutical development company, is pleased to provide its quarterly activities report and appendix 4C for the period ended 31st March 2022. https://finance.yahoo.com/news/quarterly-activities-report-appendix-4c-115500025.html

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.